These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10876814)

  • 1. [Possible involvement of serotonin receptors in anxiety disorders].
    Matsumoto M; Yoshioka M
    Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):39-44. PubMed ID: 10876814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic mechanisms in anxiety.
    Eison AS; Eison MS
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):47-62. PubMed ID: 8115673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
    Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
    Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.
    Barrett JE; Vanover KE
    Psychopharmacology (Berl); 1993; 112(1):1-12. PubMed ID: 7870996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story?
    Griebel G
    Pol J Pharmacol; 1996; 48(2):129-36. PubMed ID: 9112642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action?
    Schreiber R; De Vry J
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):87-104. PubMed ID: 8416603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced aggressive behavior in mice lacking 5-HT1B receptor.
    Saudou F; Amara DA; Dierich A; LeMeur M; Ramboz S; Segu L; Buhot MC; Hen R
    Science; 1994 Sep; 265(5180):1875-8. PubMed ID: 8091214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1B receptor knock out--behavioral consequences.
    Ramboz S; Saudou F; Amara DA; Belzung C; Segu L; Misslin R; Buhot MC; Hen R
    Behav Brain Res; 1996; 73(1-2):305-12. PubMed ID: 8788525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.
    Griebel G
    Pharmacol Ther; 1995 Mar; 65(3):319-95. PubMed ID: 7644567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiplicity of anxiety and serotonin nervous system].
    Tsuji M; Takeda H; Matsumiya T
    Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):29-38. PubMed ID: 10876813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor specificity in anxiety disorders.
    Lucki I
    J Clin Psychiatry; 1996; 57 Suppl 6():5-10. PubMed ID: 8647798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological analyses of serotonergic actions on neurons in hypothalamic ventromedial nucleus in vitro: receptor subtypes involved and implications for regulation of feeding and lordosis behaviors.
    Kow LM; Tsai YF; Wang L; Pfaff DW
    Chin J Physiol; 1992; 35(2):105-21. PubMed ID: 1451570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
    Pandey SC; Davis JM; Pandey GN
    J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors.
    Zhuang X; Gross C; Santarelli L; Compan V; Trillat AC; Hen R
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):52S-60S. PubMed ID: 10432489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.